Related Experiment Videos
Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical development
K J Harrington1, C R Lewanski, J S Stewart
1ICRF Oncology Unit, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London, UK. Harrington.Kevin@mayo.edu
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Targeting regulatory T cells for cancer immunotherapy: promises and pitfalls.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
OX40 and 4-1BB delineate distinct immune profiles in sarcoma.
Oncoimmunology·2022
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours.
Clinical and translational radiation oncology·2018
An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity.
Clinical oncology (Royal College of Radiologists (Great Britain))·2018
Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2018
Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK.
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Acute Myocardial Infarction in Head and Neck Cancer Patients and Survivors: A Population-Based Cohort Study of Patient, Disease, and Treatment Factors.
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Patient-reported Outcomes after Standard and Dose-escalated Prostate Stereotactic Body Radiotherapy.
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
A Multicentre Retrospective Cohort Study of Hypofractionated Radiotherapy in Head and Neck Cancer.
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
UK Photon Radiotherapy Practice for Oligodendroglioma -Data From the Analysis of Proton vs Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health Trial (ISRCTN:1339049) Radiotherapy Quality Assurance (RTQA) Programme.
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Whole-pelvic Versus Prostate-only Radiotherapy in Clinically Node-negative High-Risk Localised Prostate Cancer: A Systematic Review and Meta-analysis with Reconstructed Individual-patient Data.
Clinical oncology (Royal College of Radiologists (Great Britain))·2026
The Next Frontier in Quantitative Co-Clinical Imaging to Advance Functional Precision Oncology.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
G Protein-Coupled Receptor 68 Promotes the Progression of Triple-Negative Breast Cancer and Cuproptosis Resistance via the MEK/ERK Signaling Pathway.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
T Cell-Derived IFN-γ Activates Ferroptosis in Lacrimal Luminal Ductal Cells via JAK-STAT Signaling in Sjögren's Disease-Related Dry Eye.
Investigative ophthalmology & visual science·2026
A guide to transcriptional cyclin-dependent kinases in cancer.
The FEBS journal·2026
Post-Ischemic Inhibition of the Mitochondrial Ca2+ Uniporter with Ru265 Protects in Ex Vivo and In Vivo Models of Cerebral Ischemia.
Clinical science (London, England : 1979)·2026